These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 14267557)

  • 1. EXCRETION OF SV-40 VIRUS AFTER ORAL ADMINISTRATION OF CONTAMINATED POLIO VACCINE.
    HORVATH BL; FORNOSI F
    Acta Microbiol Acad Sci Hung; 1964-1965; 11():271-5. PubMed ID: 14267557
    [No Abstract]   [Full Text] [Related]  

  • 2. TRANSMISSION OF POLIO VIRUS VACCINE BY CONTAMINATED BARIUM ENEMA WITH RESULTANT ANTIBODY RISE.
    MEYERS PH; RICHARDS M
    Am J Roentgenol Radium Ther Nucl Med; 1964 Apr; 91():864-5. PubMed ID: 14139914
    [No Abstract]   [Full Text] [Related]  

  • 3. [Virus excretion and antibody formation after double oral poliomyelitis vaccination (Cox triple vaccine and Sabin vaccine)].
    JUST M; BUERGIN-WOLFF A
    Ann Paediatr; 1962; 199():245-9. PubMed ID: 14452877
    [No Abstract]   [Full Text] [Related]  

  • 4. ATTENUATED POLIOVIRUS INFECTION IN INFANTS FED COLOSTRUM FROM POLIOMYELITIS IMMUNE COWS.
    GONZAGA AJ; WARREN RJ; ROBBINS FC
    Pediatrics; 1963 Dec; 32():1039-43. PubMed ID: 14084325
    [No Abstract]   [Full Text] [Related]  

  • 5. [ORAL POLIOMYELITIS VACCINATION. ITS PRINCIPLE, USES AND METHODS FOR EXPLAINING POSSIBLE SIDE-EFFECTS].
    HAAS R
    Hippokrates; 1963 Nov; 34():843-51. PubMed ID: 14095927
    [No Abstract]   [Full Text] [Related]  

  • 6. Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination.
    Wright PF; Wieland-Alter W; Ilyushina NA; Hoen AG; Arita M; Boesch AW; Ackerman ME; van der Avoort H; Oberste MS; Pallansch MA; Burton AH; Jaffar MA; Sutter RW
    J Infect Dis; 2014 May; 209(10):1628-34. PubMed ID: 24459191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COMPARATIVE SEROLOGICAL STUDIES ON THE EFFECTIVENESS OF MONOVALENT LIVE POLIOVIRUS VACCINES GIVEN ALTERNATIVELY IN THE ORDER 2-3-1 AND 1-3-2.
    FORNOSI F; TALOS I
    Acta Microbiol Acad Sci Hung; 1964-1965; 11():263-9. PubMed ID: 14267556
    [No Abstract]   [Full Text] [Related]  

  • 8. [STUDIES ON THE CAUSES OF INTESTINAL RESISTANCE TO POLIO. RESULTS IN THE DETERMINATION OF POLIO NEUTRALIZING SUBSTANCES IN THE FECES].
    KAWAKAMI K; TATSUMI M
    Sogo Rinsho; 1964 Jul; 13():1189-96. PubMed ID: 14176096
    [No Abstract]   [Full Text] [Related]  

  • 9. [METHODS AND RESULTS OF PREPARATION OF LIVE POLIOMYELITIS VACCINE, NOT CONTAINING MIXTURES OF VACUOLIZING VIRUS (OB40-SV40)].
    CHUMAKOV MP; DZAGUROV SG; LASHKEVICH VA; GRACHEV VP; MIRONOVA LL; RALF NM; ELBERT LB
    Vopr Virusol; 1963; 29():445-9. PubMed ID: 14071282
    [No Abstract]   [Full Text] [Related]  

  • 10. [FIELD TRIAL WITH LIVE ORAL POLIOVIRUS VACCINE. I. SCHEDULE OF THIS TRIAL AND EXCRETION OF VIRUS IN FECES AFTER THE ADMINISTRATION OF MONOVALENT ORAL POLIOVIRUS VACCINE].
    URASAWA S; OGAWA M; KANNO T
    Sapporo Igaku Zasshi; 1963 Mar; 23():194-201. PubMed ID: 14057342
    [No Abstract]   [Full Text] [Related]  

  • 11. Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral poliovaccine.
    MELNICK JL; STINEBAUGH S
    Proc Soc Exp Biol Med; 1962 Apr; 109():965-8. PubMed ID: 14472428
    [No Abstract]   [Full Text] [Related]  

  • 12. IMMUNOLOGIC RESPONSE TO ORAL POLIOMYELITIS VACCINE.
    ANDELMAN SL
    IMJ Ill Med J; 1963 Aug; 124():131-3. PubMed ID: 14046358
    [No Abstract]   [Full Text] [Related]  

  • 13. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
    Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA
    J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isolates of poliovirus vaccine and immune response to different doses of oral polio vaccine].
    Más Lago P; Díaz J; Díaz Gonzalez M; Goyenechea Hernández A; Barrio Olivera J; Fonseca Quintana M; Morier Díaz L; Sarmiento Pérez L; Palomera Puente R
    Rev Cubana Med Trop; 2005; 57(2):111-9. PubMed ID: 17966580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paralytic poliomyelitis caused by a vaccine-derived polio virus in an antibody-deficient Argentinean child.
    Hidalgo S; García Erro M; Cisterna D; Freire MC
    Pediatr Infect Dis J; 2003 Jun; 22(6):570-2. PubMed ID: 12828159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies of the effect poliomyelitis live vaccine (Sabin) in small infants].
    Hussels H; Hennessen W
    Med Klin; 1966 Feb; 61(5):165-7. PubMed ID: 4293160
    [No Abstract]   [Full Text] [Related]  

  • 17. Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India.
    Mohanty MC; Madkaikar MR; Desai M; Taur P; Nalavade UP; Sharma DK; Gupta M; Dalvi A; Shabrish S; Kulkarni M; Aluri J; Deshpande JM
    Emerg Infect Dis; 2017 Oct; 23(10):1664-1670. PubMed ID: 28930011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ANTIBODY FORMATION AFTER 3 DOSES OF QUADRUPLE VACCINE INJECTION FOLLOWED BY TRIVALENT ORAL POLIOMYELITIS VACCINE].
    HENIGST W; MUELLER F
    Dtsch Med Wochenschr; 1965 Aug; 90():1502-6. PubMed ID: 14344415
    [No Abstract]   [Full Text] [Related]  

  • 19. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINE. III. IS THERE INTERFERENCE BY SV 40 AGAINST POLIOVIRUS?].
    GUENTHER O; VON METTENHEIM ; HOEVEL H
    Zentralbl Bakteriol Orig; 1964 Feb; 192():1-11. PubMed ID: 14176847
    [No Abstract]   [Full Text] [Related]  

  • 20. TRIVALENT ORAL POLIO VACCINE: CLINICAL TRIAL OF A NEW FORMULATION.
    BURKE DM; GOW RC
    Clin Pediatr (Phila); 1963 Sep; 2():517-20. PubMed ID: 14047178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.